spacer
home > ict > winter 2017 > up and coming
PUBLICATIONS
International Clinical Trials

Up and Coming

In Sub-Saharan Africa, South Africa remains the optimal location for trials. It accounts for approximately 58% of the total clinical studies conducted within the region and continues to operate as a regional hub. South Africa’s regulatory framework and relatively high level of healthcare infrastructure and public health system make it attractive for trials (1).

The majority of trials that take place in Sub-Saharan Africa are grant-funded and focus on infectious diseases such as HIV, tuberculosis (TB) and malaria. Countries like Burkina Faso, Ghana, Kenya, Malawi, Mali and Tanzania are emerging as viable locations. Both pharmaceutical companies and CROs have been expanding their presence throughout Kenya in the east and Ghana in the west, whereas Nigeria is emerging as a satellite hub to support the growth of clinical trials in this region. Efforts should be taken to harmonise regulatory protocols for the conduct of studies across the continent as most of the guidelines currently vary from country to country.

Development Opportunities

To promote the conduct of clinical research in the region, the Pan African Clinical Trials Registry (PACTR) was established by the South African Cochrane Centre in collaboration with the European and Developing Countries Clinical Trials Partnership and the Cochrane Infectious Disease Group. It is an official registry affiliated with the WHO Network of Primary Registers. The PACTR also provides data to the central WHO International Clinical Trials Registry Platform, so that studies listed in the archive are available through a global platform (2).

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Saravanan Thangaraj is a Senior Research Analyst in the Transformational Health group at Frost & Sullivan. He has over three years of experience in management consulting, has advised clients on strategy and business and has also authored many off-the-shelf industry insight reports during his time at the company. Saravanan’s experience includes biotechnology, pharma, life sciences, in vitro diagnostic devices and health systems. He holds a Bachelor of Technology in Biotechnology and a Master of Business Administration from PSG College of Technology, India.
spacer
Saravanan Thangaraj
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

HATRIC-based identification of receptors for orphan ligands (small molecules)

HATRIC-LRC (Ligand Receptor Capture) enables now the identification of small molecule targets on the surface of living cells! Even primary cells!
More info >>

White Papers

Utilising Big Data to Produce Faster and Cheaper Clinical Research

Medical Research Network (MRN) Limited

Recruitment and retention of patients remains the major challenge to ensuring trials run as fast as possible and give them the statistical power they are designed to produce. This is not just about getting better any more - but about stopping the deterioration of these metrics in modern clinical trials.
More info >>

 
Industry Events

SAPHEX 2018

1-2 November 2018, Gallagher Convention Centre, Midrand, South Africa

The SAPHEX exhibition and conference is now established as the “go-to” networking and business event for anyone working in the South African pharmaceutical manufacturing industry.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement